Ocular Adnexal Lymphoma Associated With IgG4+ Chronic Sclerosing Dacryoadenitis: A Previously Undescribed Complication of IgG4-related Sclerosing Disease-Reference-Cited by-同舟云学术

Ocular Adnexal Lymphoma Associated With IgG4+ Chronic Sclerosing Dacryoadenitis: A Previously Undescribed Complication of IgG4-related Sclerosing Disease

Published:2008-08 Issue:8 Volume:32 Page:1159-1167
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Cheuk Wah,Yuen Hunter K. L.,Chan Alexander C. L.,Shih Lee-Yung,Kuo Tseng-Tong,Ma Ming-Wai,Lo Yan-Fai,Chan Wai-Kong,Chan John K. C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference15 articles.

1. Malignant lymphomas of the thyroid gland. Analysis of 79 patients with emphasis on histologic prognostic factors;Aozasa;Cancer,1986

2. Autoimmune pancreatitis: prototype of IgG4-related sclerosing disease;Cheuk;Adv Anat Pathol,2007

3. Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related sclerosing disease?;Cheuk;Am J Surg Pathol,2007

4. Lymphoma of the ocular adnexa: a study of 353 cases;Ferry;Am J Surg Pathol,2007

5. High serum IgG4 concentrations in patients with sclerosing pancreatitis;Hamano;N Engl J Med,2001

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orbit;Ocular Pathology;2025

2. Elevated polyclonal IgG4 mimicking a monoclonal gammopathy in IgG4-related disease—a case-based review;Clinical Rheumatology;2024-07-11

3. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease;Japanese Journal of Ophthalmology;2024-07

4. Histopathologic clues to the etiopathogenesis of orbital inflammatory disease: Idiopathic, IgG4-related, neoplastic, autoimmune and beyond;Seminars in Diagnostic Pathology;2024-03

5. Construction and validation of a novel web-based nomogram for primary ocular adnexal lymphoma: a real-world analysis based on the Surveillance, Epidemiology, and End Results database;Translational Cancer Research;2024-02